Koers Nutra Pharma Corp. Other OTC
Aandelen
NPHC
US67060U2087
Biotechnologie & Medisch Onderzoek
Omzet 2020 | 51,9K 48,39K | Omzet 2021 | 97,74K 91,12K | Marktkapitalisatie | 14,65 mln. 13,66 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2020 | - 0 | Nettowinst (verlies) 2021 | -13 mln. -12,12 mln. | EV/omzet 2020 | 238 x |
Nettoschuld 2020 | 5,24 mln. 4,88 mln. | Nettoschuld 2021 | 8,3 mln. 7,74 mln. | EV/omzet 2021 | 235 x |
K/w-verhouding 2020 |
-10,3
x | K/w-verhouding 2021 |
-1,1
x | Werknemers | - |
Dividendrendement 2020 * |
-
| Dividendrendement 2021 |
-
| Vrij verhandelbaar | 100% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 62 | 27-07-16 | |
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07-11-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rik Deitsch
PRN | Corporate Officer/Principal | 56 | 07-11-02 |
Stewart Lonky
BRD | Director/Board Member | 75 | 05-11-04 |
Garry Pottruck
BRD | Director/Board Member | 65 | 29-07-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,28% | 42,68 mld. | |
-3,99% | 42,4 mld. | |
+45,32% | 40,04 mld. | |
-6,20% | 28,31 mld. | |
+6,36% | 24,94 mld. | |
-21,47% | 18,96 mld. | |
+27,58% | 12,3 mld. | |
-2,75% | 11,95 mld. | |
-2,02% | 11,55 mld. |